Contact
searchSearch
HMP Global

Volume 28 - Issue 4 - April, 2016

Department

Letters to the Editor
A Paradigm Shift Toward Forearm Arterial Access Requires Establishing Preprocedure Adequacy of Hand Collateralization or Patency of Collateralizing Forearm Arteries
03/29/2016
Yashasvi Chugh, MD; Sunita Chugh, MBBS, MASE; Sanjay Chugh, MD, DM
The authors offer their opinion on forearm arterial access and the January 2016 article by Gokhroo et al.  
The authors offer their opinion on forearm arterial access and the January 2016 article by Gokhroo et al.  
The authors offer their opinion...
03/29/2016
Journal of Invasive Cardiology
Balloon-Assisted Microdissection "BAM" Technique for Balloon-Uncrossable Chronic Total Occlusions
03/29/2016
J. Aaron Grantham, MD; Minh N. Vo, MD; Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FESC, FSCAI; William L. Lombardi, MD; Georgios Christopoulos, MD; Dimitrios Karmpaliotis, MD, PhD
We evaluated the safety and efficacy of the balloon-assisted microdissection (BAM) technique for treating balloon-uncrossable chronic total occlusion lesions.
We evaluated the safety and efficacy of the balloon-assisted microdissection (BAM) technique for treating balloon-uncrossable chronic total occlusion lesions.
We evaluated the safety and...
03/29/2016
Journal of Invasive Cardiology

Insights

Commentary
Side-Branch Occlusions in Coronary CTO-PCI: Avoid or Forget?
03/29/2016
Farouc A. Jaffer, MD, PhD; Peter P. Monteleone, MD
The results of the Nguyen-Trong study are hypothesis generating and encourage further investigation into the importance of SB loss during CTO-PCI. Should additional studies find conclusively worse outcomes following SB loss, it will become...
The results of the Nguyen-Trong study are hypothesis generating and encourage further investigation into the importance of SB loss during CTO-PCI. Should additional studies find conclusively worse outcomes following SB loss, it will become...
The results of the Nguyen-Trong...
03/29/2016
Journal of Invasive Cardiology
Commentary
Spontaneous Echo Contrast and TAVR: A Smoking Gun?
03/29/2016
Saif Anwaruddin, MD; Paul N. Fiorilli, MD
Overall, as the use of TAVR continues to expand, the role for identifying which patients are at a higher risk of an adverse outcome post procedure has become increasingly important.
Overall, as the use of TAVR continues to expand, the role for identifying which patients are at a higher risk of an adverse outcome post procedure has become increasingly important.
Overall, as the use of TAVR...
03/29/2016
Journal of Invasive Cardiology
Commentary
Percutaneous Extracorporeal Membrane Oxygenation: The Newest Iteration of Temporary Mechanical Support for the Left Ventricle
03/29/2016
David M. Shavelle, MD, FACC, FSCAI
Use of objective scoring systems, additional operator experience with newer devices, and additional clinical trials will hopefully help clinicians accurately identify patients who will derive benefit from temporary LV support.
Use of objective scoring systems, additional operator experience with newer devices, and additional clinical trials will hopefully help clinicians accurately identify patients who will derive benefit from temporary LV support.
Use of objective scoring...
03/29/2016
Journal of Invasive Cardiology

Feature

Original Contribution
Spontaneous Echocardiographic Contrast in the Left Atrium During Transcatheter Aortic Valve Replacement is Associated With Worse Outcomes
03/29/2016
David Paul Slovut, MD, PhD; Anthony A. Holmes, MD; Cynthia C. Taub, MD; Tomo Ando, MD
We assessed the impact of spontaneous echocardiographic contrast on outcomes after TAVR by retrospectively reviewing the medical records of 93 consecutive patients who underwent TAVR at a single center.
We assessed the impact of spontaneous echocardiographic contrast on outcomes after TAVR by retrospectively reviewing the medical records of 93 consecutive patients who underwent TAVR at a single center.
We assessed the impact of...
03/29/2016
Journal of Invasive Cardiology
Original Contribution
Percutaneous Coronary Intervention in Severely Calcified Unprotected Left Main Coronary Artery Disease: Initial Experience With Orbital Atherectomy
03/29/2016
Richard A. Shlofmitz, MD; Evan Shlofmitz, DO; Michael S. Lee, MD, DPM, FACFAS, FACC, FSCAI; Barry Kaplan, MD
We retrospectively report clinical outcomes of 14 patients who underwent PCI with orbital atherectomy for severely calcified ULMCA disease from May 2014 to July 2015.
We retrospectively report clinical outcomes of 14 patients who underwent PCI with orbital atherectomy for severely calcified ULMCA disease from May 2014 to July 2015.
We retrospectively report...
03/29/2016
Journal of Invasive Cardiology
Original Contribution
Sequential Organ Failure Assessment Score at Presentation Predicts Survival in Patients Treated With Percutaneous Veno-Arterial Extracorporeal Membrane Oxygenation
02/15/2016
Elizabeth M. Retzer, MD; Valluvan Jeevanandam, MD; Janet Friant, MSN, APN; Nir Uriel, MD, MSc; Sandeep Nathan, MD, MSc, FACC, FSCAI; Atman P. Shah, MD, FACC, FSCAI; Joseph M. Venturini, MD; Mark J. Russo, MD, MS; Peter Czobor, MD; Kishan S. Parikh, MD; Jonathan D. Paul, MD; John E.A. Blair, MD
A study on demographic, clinical, and procedural determinants of outcomes in patients treated with percutaneous VA-ECMO initiated in the cath lab.  
A study on demographic, clinical, and procedural determinants of outcomes in patients treated with percutaneous VA-ECMO initiated in the cath lab.  
A study on demographic,...
02/15/2016
Journal of Invasive Cardiology
Original Contribution
Predictors and Outcomes of Side-Branch Occlusion in Coronary Chronic Total Occlusion Interventions
01/15/2016
Barbara Anna Danek, MD; Bavana V. Rangan, BDS, MPH, MD; Jerrold M. Grodin, MD; Michael Luna, MD; Shuaib M. Abdullah, MD; Dharam J. Kumbhani, MD, SM; Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FESC, FSCAI; Tayo Addo, MD; Subhash Banerjee, MD, FSCAI; José Roberto Martínez-Parachini, MD; Erica Resendes, BS, MS, MPH; Colby R. Ayers, MS; Phuong-Khanh J. Nguyen-Trong, MD; Aris Karatasakis, MD; Georgios E. Christakopoulos, MD
An investigation on whether side-branch loss during CTO-PCI could adversely impact clinical outcomes. 
An investigation on whether side-branch loss during CTO-PCI could adversely impact clinical outcomes. 
An investigation on whether...
01/15/2016
Journal of Invasive Cardiology
Original Contribution
Impact of Contrast Dose Reduction on Incidence of Acute Kidney Injury (AKI) Among Patients Undergoing PCI: A Modeling Study
01/15/2016
Roxana Mehran, MD; Hitinder S. Gurm, MBBS, MD, FSCAI; Cindy L. Grines, MD, FACC, FSCAI; Thomas A. LaLonde, MD; Milan Seth, BS, MS; Carlo Briguori, MD, PhD; Louis Cannon, MD, FACC, FACP
This study estimates projected reduction in the burden of AKI in association with contrast media dose reduction in PCI patients.
This study estimates projected reduction in the burden of AKI in association with contrast media dose reduction in PCI patients.
This study estimates projected...
01/15/2016
Journal of Invasive Cardiology

News

Mitral Valve Intervention
Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System
04/14/2025
The SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic (moderate-to-severe or severe) mitral regurgitation (MR) who are deemed unsuitable for surgery or transcatheter...
The SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic (moderate-to-severe or severe) mitral regurgitation (MR) who are deemed unsuitable for surgery or transcatheter...
The SAPIEN M3 mitral valve...
04/14/2025
Cath Lab Digest
quantitative flow ratio
Medis QFR 3.0 Launches in the U.S.
04/07/2025
Medis QFR® is a safe(1) and wire-free software solution that assesses angiography-derived coronary physiology in patients with ischemic CAD. Medis QFR® is a wire-free technique that estimates FFR values using computational fluid dynamics...
Medis QFR® is a safe(1) and wire-free software solution that assesses angiography-derived coronary physiology in patients with ischemic CAD. Medis QFR® is a wire-free technique that estimates FFR values using computational fluid dynamics...
Medis QFR® is a safe(1) and...
04/07/2025
Cath Lab Digest
Intravascular Lithotripsy
Shockwave Medical Enrolls First Patient in FORWARD CAD Pivotal Study of Novel Forward Intravascular Lithotripsy Platform
04/07/2025
Investigators in the study will assess the safety and effectiveness of the Shockwave Javelin Coronary IVL Catheter for the treatment of calcified, difficult-to-cross stenotic de novo coronary artery lesions prior to stenting.
Investigators in the study will assess the safety and effectiveness of the Shockwave Javelin Coronary IVL Catheter for the treatment of calcified, difficult-to-cross stenotic de novo coronary artery lesions prior to stenting.
Investigators in the study will...
04/07/2025
Cath Lab Digest
thrombectomy
Seven New Data Sets Demonstrate Penumbra’s Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits
04/07/2025
Penumbra, Inc, announced seven significant computer assisted vacuum thrombectomy (CAVT™) data presentations during the 2025 Society of Interventional Radiology (SIR) Annual Scientific Meeting. The data showed that CAVT as a frontline therapy...
Penumbra, Inc, announced seven significant computer assisted vacuum thrombectomy (CAVT™) data presentations during the 2025 Society of Interventional Radiology (SIR) Annual Scientific Meeting. The data showed that CAVT as a frontline therapy...
Penumbra, Inc, announced seven...
04/07/2025
Cath Lab Digest
Intravascular Imaging
ECLIPSE Trial: Intravascular Imaging Can Improve Outcomes for Complex Stenting Procedures in Patients with High-Risk Calcified CAD
03/31/2025
“The ECLIPSE trial shows that use of intravascular imaging (IVI) to guide coronary stenting in severely calcified lesions prevents death, stent thrombosis, and unplanned repeat procedures in this high-risk patient population,” says first...
“The ECLIPSE trial shows that use of intravascular imaging (IVI) to guide coronary stenting in severely calcified lesions prevents death, stent thrombosis, and unplanned repeat procedures in this high-risk patient population,” says first...
“The ECLIPSE trial shows that...
03/31/2025
Cath Lab Digest
Aortic Stenosis
New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients
03/31/2025
New data from DETECT AS and the EARLY TAVR Trial were presented at ACC.25 in Chicago, addressing the critical needs of patients with structural heart disease.
New data from DETECT AS and the EARLY TAVR Trial were presented at ACC.25 in Chicago, addressing the critical needs of patients with structural heart disease.
New data from DETECT AS and the...
03/31/2025
Cath Lab Digest
CAD in Women
New Intermountain Health Study Finds Gap Between Heart Disease Outcomes in Men and Women Has Narrowed Over Past 20 Years  
03/31/2025
Women studied tended to be older with more comorbidities (like high blood pressure, diabetes, and history of stroke and heart failure), have more stable chest pain, and experience less severe chest pain or heart attack when they came into the...
Women studied tended to be older with more comorbidities (like high blood pressure, diabetes, and history of stroke and heart failure), have more stable chest pain, and experience less severe chest pain or heart attack when they came into the...
Women studied tended to be older...
03/31/2025
Cath Lab Digest
AI
HeartFocus Clinical Trial Proves AI Can Empower Novices to Deliver Diagnostic-Quality Cardiac Ultrasounds
03/31/2025
Results showed that 100% of exams conducted by novices using HeartFocus met the diagnostic standards for all primary endpoints, with a strong correlation to expert-acquired scans across qualitative and quantitative assessments.
Results showed that 100% of exams conducted by novices using HeartFocus met the diagnostic standards for all primary endpoints, with a strong correlation to expert-acquired scans across qualitative and quantitative assessments.
Results showed that 100% of...
03/31/2025
Cath Lab Digest
plaque analysis
CONFIRM2 Registry: Late-Breaking Clinical Trial Results Demonstrate the Predictive Power of Cleerly's AI-QCT for Women’s Cardiovascular Risk at ACC.25
03/31/2025
The findings demonstrate that AI-QCT features of coronary artery disease (CAD), as detected by Cleerly’s AI-QCT, can identify women at high risk for major adverse cardiovascular events (MACE) and improves risk stratification - a population...
The findings demonstrate that AI-QCT features of coronary artery disease (CAD), as detected by Cleerly’s AI-QCT, can identify women at high risk for major adverse cardiovascular events (MACE) and improves risk stratification - a population...
The findings demonstrate that...
03/31/2025
Cath Lab Digest
Statins
CorCal Outcomes Study: Who Needs a Statin? Intermountain Study Compares Prescribing Recommendations Based on Traditional Risk Factors vs. Coronary Artery Calcium Scoring
03/31/2025
The research is part of CorCal Outcomes, a large, randomized clinical trial at Intermountain Health that is comparing the PCE versus CAC score guidance to initiate a statin prescription for patients for primary prevention of coronary heart...
The research is part of CorCal Outcomes, a large, randomized clinical trial at Intermountain Health that is comparing the PCE versus CAC score guidance to initiate a statin prescription for patients for primary prevention of coronary heart...
The research is part of CorCal...
03/31/2025
Cath Lab Digest

Mitral Valve Intervention
Edwards SAPIEN M3 Receives CE Mark, Becoming World’s First Transfemoral Transcatheter Mitral Valve Replacement System
04/14/2025
The SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic (moderate-to-severe or severe) mitral regurgitation (MR) who are deemed unsuitable for surgery or transcatheter...
The SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic (moderate-to-severe or severe) mitral regurgitation (MR) who are deemed unsuitable for surgery or transcatheter...
The SAPIEN M3 mitral valve...
04/14/2025
Cath Lab Digest
Murai Figure
Clinical Videos
Intravascular Lithotripsy for In-Stent Calcified Neoatherosclerosis
04/09/2025
Video Supplement to "Intravascular Lithotripsy for In-Stent Calcified Neoatherosclerosis" (Clinical Image).
Video Supplement to "Intravascular Lithotripsy for In-Stent Calcified Neoatherosclerosis" (Clinical Image).
Video Supplement to...
04/09/2025
Journal of Invasive Cardiology
Clinical Images
Intravascular Lithotripsy for In-Stent Calcified Neoatherosclerosis
04/09/2025
Keima Wayama, MD; Kota Murai, MD, PhD; Teruo Noguchi, MD, PhD
An 80-year-old man with a history of acute inferior myocardial infarction was admitted to our hospital. He had undergone bare-metal stent (3.5/28 mm) implantation in the mid-right coronary artery 22 years prior.
An 80-year-old man with a history of acute inferior myocardial infarction was admitted to our hospital. He had undergone bare-metal stent (3.5/28 mm) implantation in the mid-right coronary artery 22 years prior.
An 80-year-old man with a...
04/09/2025
Journal of Invasive Cardiology
quantitative flow ratio
Medis QFR 3.0 Launches in the U.S.
04/07/2025
Medis QFR® is a safe(1) and wire-free software solution that assesses angiography-derived coronary physiology in patients with ischemic CAD. Medis QFR® is a wire-free technique that estimates FFR values using computational fluid dynamics...
Medis QFR® is a safe(1) and wire-free software solution that assesses angiography-derived coronary physiology in patients with ischemic CAD. Medis QFR® is a wire-free technique that estimates FFR values using computational fluid dynamics...
Medis QFR® is a safe(1) and...
04/07/2025
Cath Lab Digest
Agstam Figure
Clinical Videos
Tenecteplase-Assisted Transapical Drainage of Tuberculous Pyopericardium
04/07/2025
Video Supplement to "Tenecteplase-Assisted Transapical Drainage of Tuberculous Pyopericardium" (Clinical Image).
Video Supplement to "Tenecteplase-Assisted Transapical Drainage of Tuberculous Pyopericardium" (Clinical Image).
Video Supplement to...
04/07/2025
Journal of Invasive Cardiology
Clinical Images
Tenecteplase-Assisted Transapical Drainage of Tuberculous Pyopericardium
04/07/2025
Venkatakrishnan Ramakumar, MD, DM; Durlabhesh Rawat, MD, DM; Sourabh Agstam, MD, DM
A 35-year-old man with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) and a CD4 count of 61 cells per mm3 (normal range: 500-1200 cells/mm3) presented with worsening shortness of breath and orthopnoea over the...
A 35-year-old man with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) and a CD4 count of 61 cells per mm3 (normal range: 500-1200 cells/mm3) presented with worsening shortness of breath and orthopnoea over the...
A 35-year-old man with human...
04/07/2025
Journal of Invasive Cardiology
Intravascular Lithotripsy
Shockwave Medical Enrolls First Patient in FORWARD CAD Pivotal Study of Novel Forward Intravascular Lithotripsy Platform
04/07/2025
Investigators in the study will assess the safety and effectiveness of the Shockwave Javelin Coronary IVL Catheter for the treatment of calcified, difficult-to-cross stenotic de novo coronary artery lesions prior to stenting.
Investigators in the study will assess the safety and effectiveness of the Shockwave Javelin Coronary IVL Catheter for the treatment of calcified, difficult-to-cross stenotic de novo coronary artery lesions prior to stenting.
Investigators in the study will...
04/07/2025
Cath Lab Digest
thrombectomy
Seven New Data Sets Demonstrate Penumbra’s Computer Assisted Vacuum Thrombectomy (CAVT) Technology Is Safe, Fast and Effective, Improves Patient Outcomes, and Delivers Healthcare Resource Benefits
04/07/2025
Penumbra, Inc, announced seven significant computer assisted vacuum thrombectomy (CAVT™) data presentations during the 2025 Society of Interventional Radiology (SIR) Annual Scientific Meeting. The data showed that CAVT as a frontline therapy...
Penumbra, Inc, announced seven significant computer assisted vacuum thrombectomy (CAVT™) data presentations during the 2025 Society of Interventional Radiology (SIR) Annual Scientific Meeting. The data showed that CAVT as a frontline therapy...
Penumbra, Inc, announced seven...
04/07/2025
Cath Lab Digest
Original Contribution
Rotational Atherectomy for Calcified Coronary Lesions in Severe Aortic Stenosis Before Transcatheter Aortic Valve Implantation
04/04/2025
Sultan Alotaibi, MD, MSc; Abdelhakim Allali, MD; Hajo Heyer, MD; Nader Mankerious, MD; Martin Landt, MD; Mohamed Abdel-Wahab, MD; Volker Geist, MD; Ralph Tölg, MD; Mohamed Samy, MD; Gert Richardt, MD; Karim Elbasha, MD
The authors aimed to compare in-hospital outcomes following rotational atherectomy in patients with severe aortic stenosis (AS) before transcatheter aortic valve implantation vs patients without AS.
The authors aimed to compare in-hospital outcomes following rotational atherectomy in patients with severe aortic stenosis (AS) before transcatheter aortic valve implantation vs patients without AS.
The authors aimed to compare...
04/04/2025
Journal of Invasive Cardiology
Original Contribution
Can IodixAnol ReducE the Incidence of Adverse Renal or Cardiac Events in Chronic Total Occlusion Interventions (CARE-CTO): A Substudy of the PROGRESS-CTO Registry
04/02/2025
Dimitrios Strepkos, MD; Athanasios Rempakos, MD; Michaella Alexandrou, MD; Deniz Mutlu, MD; Pedro E.P. Carvalho, MD; Ozgur Selim Ser, MD; Khaldoon Alaswad, MD; Mir Babar Basir, DO; Dmitrii Khelimskii, MD; Oleg Krestyaninov, MD; Jaikirshan J. Khatri, MD; Laura D. Young, MD; Omer Goktekin, MD; Paul Poommipanit, MD; Farouc A. Jaffer, MD, PhD; Sevket Gorgulu, MD; Ahmed M. ElGuindy, MD; Nidal Abi Rafeh, MD; Olga C. Mastrodemos, BA; Bavana V. Rangan, BDS, MPH; Sandeep Jalli, DO; Konstantinos Voudris, MD, PhD; Yader Sandoval, MD; M. Nicholas Burke, MD; Emmanouil S. Brilakis, MD, PhD
The impact of contrast type in chronic total occlusion (CTO) percutaneous coronary intervention (PCI) remains controversial. The authors sought to evaluate the impact of contrast medium selection on patients undergoing CTO PCI.
The impact of contrast type in chronic total occlusion (CTO) percutaneous coronary intervention (PCI) remains controversial. The authors sought to evaluate the impact of contrast medium selection on patients undergoing CTO PCI.
The impact of contrast type in...
04/02/2025
Journal of Invasive Cardiology

April 2016 Volume 28 Issue 4

View Issue Archive
Editorial Correspondence

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use